The Swiss drugmaker expects sales and core earnings per share to grow at constant currencies this year, partly due to the strength of its drug pipeline.
Source link
Roche Forecasts 2026 Growth, Cites Drug-Pipeline Strength
Date:
More like thisRelated
Anyone who has used CVS' website is owed money. Here's how to get a payment
Are you a CVS customer? Or have you ever...
Garth Brooks’ TuneIn Partnership Ends Abruptly After Three Years
Garth Brooks and TuneIn are no longer business partners....
Trump Weighs Diesel Export Ban as Fuel Prices Soar
The president said a decision would come “fast” on...